0.0002
0.0000
(0.00%)
At close: January 30 at 3:00:00 PM EST
Breakdown
TTM
Operating Expense
13,038.0000
Operating Income
-13,038.0000
Net Non Operating Interest Income Expense
-853.0000
Pretax Income
-13,891.0000
Net Income Common Stockholders
-13,891.0000
Diluted NI Available to Com Stockholders
-13,891.0000
Basic EPS
-0.85
Diluted EPS
-0.85
Basic Average Shares
11,701.5000
Diluted Average Shares
11,701.5000
Total Operating Income as Reported
-13,038.0000
Total Expenses
13,038.0000
Net Income from Continuing & Discontinued Operation
-13,891.0000
Normalized Income
-13,891.0000
Interest Income
90.0000
Interest Expense
943.0000
Net Interest Income
-853.0000
EBIT
-12,948.0000
EBITDA
-12,865.0000
Reconciled Depreciation
83.0000
Net Income from Continuing Operation Net Minority Interest
-13,891.0000
Normalized EBITDA
-12,865.0000
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1873.HK VIVA BIOTECH
0.800
-2.44%
TCRX TScan Therapeutics, Inc.
2.5700
-0.39%
ONWD.BR Onward Medical N.V.
6.36
+0.95%
CELC Celcuity Inc.
11.95
+1.96%
AVCT.L Avacta Group Plc
47.50
-1.04%
OXB.L Oxford Biomedica plc
417.00
+0.97%
GTBP GT Biopharma, Inc.
2.2300
+8.25%
NUVL Nuvalent, Inc.
85.81
-2.21%
ONT.L Oxford Nanopore Technologies plc
145.80
+0.69%
SNGX Soligenix, Inc.
2.3300
+0.87%